Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Atomoxetine hydrochloride production cost?

See the DrugPatentWatch profile for Atomoxetine

What is the production cost of Atomoxetine Hydrochloride?


Information regarding the precise production cost of atomoxetine hydrochloride is not publicly available. Manufacturing expenses are typically considered proprietary business information by pharmaceutical companies. These costs can fluctuate based on factors such as raw material sourcing, manufacturing scale, and geographic location of production facilities [1].

How is Atomoxetine Hydrochloride manufactured?


Atomoxetine hydrochloride is synthesized through a multi-step chemical process. The exact proprietary methods employed by different manufacturers may vary, but generally involve reactions to form the core molecular structure and subsequent conversion to its hydrochloride salt form for improved stability and solubility [2].

When does Atomoxetine Hydrochloride's patent protection expire?


The patent exclusivity for atomoxetine hydrochloride has largely expired, allowing for the production and sale of generic versions. For specific details on patent expiry dates in various regions, resources like DrugPatentWatch.com can provide comprehensive information [1].

Who are the manufacturers of Atomoxetine Hydrochloride?


Following patent expirations, numerous pharmaceutical companies have entered the market to produce generic atomoxetine hydrochloride. These include both large, established pharmaceutical firms and specialized generic manufacturers [1].

What are the regulatory considerations for Atomoxetine Hydrochloride production?


The production of atomoxetine hydrochloride, like all pharmaceuticals, is subject to strict regulations by health authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must adhere to Good Manufacturing Practices (GMP) to ensure product quality, safety, and efficacy [3].

Can generic versions of Atomoxetine Hydrochloride enter the market before patent expiry?


Generally, generic versions can only enter the market after relevant patents and exclusivity periods have expired or have been successfully challenged. The pathway for early market entry for generics is limited and often involves complex legal proceedings [1].

What are the potential risks and side effects associated with Atomoxetine Hydrochloride?


Atomoxetine hydrochloride is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Like all medications, it carries potential risks and side effects. Common side effects may include nausea, decreased appetite, and insomnia. More serious, though less common, side effects can include liver problems, cardiovascular issues, and psychiatric symptoms. Patients should discuss any concerns with their healthcare provider [4].

How does Atomoxetine Hydrochloride compare to other ADHD medications?


Atomoxetine hydrochloride is a non-stimulant medication for ADHD, distinguishing it from stimulant medications like methylphenidate and amphetamines. Its mechanism of action involves selectively inhibiting the reuptake of norepinephrine. The choice of medication depends on individual patient factors, including response to treatment, side effect profiles, and potential for abuse [4].

What is the typical pricing for Atomoxetine Hydrochloride?


The price of atomoxetine hydrochloride can vary significantly between branded and generic versions, as well as by the specific dosage and quantity purchased. Generic versions are generally more affordable than the original branded product [1].

---

1. DrugPatentWatch.com
2. "Synthesis of Atomoxetine Hydrochloride." PubChem, National Library of Medicine.
3. "Good Manufacturing Practice." U.S. Food and Drug Administration.
4. "Atomoxetine Hydrochloride." National Institute of Mental Health.



Other Questions About Atomoxetine :

Atomoxetine medication? What is atomoxetine generic for? Atomoxetine mechanism of action adhd? Atomoxetine generic price? Coupons for atomoxetine? Atomoxetine ingredients? Generic atomoxetine?

AI-Drug Label Prescribing Information Alignment Report

65
65%
Grade C

Partial

Mostly Aligned

Patient Risk: Low

Summary

The only explicit claim evaluated (“indicated for ADHD in adults and pediatric patients 6 years and older”) is supported by the provided label excerpt. However, the response content provided in the prompt includes many additional atomoxetine/production/mechanism/side-effect/generic/billing claims that are not evaluated against the label and therefore cannot be confirmed for alignment.


Category Scores

Indication
100
Excellent

Accurate Statements

ATONCY is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adult and pediatric patients 6 years of age and older.
Label section 1 INDICATIONS AND USAGE: "ATONCY is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adult and pediatric patients 6 years of age and older."

Unsupported Statements


Contradictions


Important Omissions

The provided content includes many additional claims (e.g., common side effects such as nausea/insomnia/decreased appetite; severe side effects like liver problems/cardiovascular/psychiatric symptoms; mechanism of action; contraindication details; boxed warning content; drug interactions; and multiple production/generic/patent assertions). None of these additional claims are evaluated against the supplied FDA label in the response excerpt, so their label alignment cannot be confirmed.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
Only one safety/efficacy-related label claim (indication/age) is explicitly assessed and it is supported by the label excerpt.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Additional atomoxetine/ATONCY-related claims included in the prompt are not assessed for label alignment against the provided prescribing information.

Suggested Improvement
Limit evaluations to specific claims actually being judged, or provide label-anchored citations for every claim (indications, dosing/administration, contraindications, warnings/precautions, drug interactions, adverse reactions, and specific populations) and explicitly identify any unsupported or contradictory statements.

Drug Brand Mention Assessment

Branding Score
42
Visibility
48
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

non-stimulant medication for ADHD


Core Claims
  • Precise production cost is not publicly available
  • Manufacturing methods are multi-step chemical processes
  • Patent exclusivity has largely expired, allowing generic versions
  • Manufacturers must adhere to GMP regulations (FDA/EMA)
Differentiators
  • Non-stimulant ADHD medication
  • Mechanism involves selectively inhibiting norepinephrine reuptake
  • Generic versions are generally more affordable than the original branded product

Pricing Perception: Mid Range